A 33-year-old gravida 2 at 34 weeks in October asks about RSV protection for her newborn. She declines monoclonal antibody after birth. What maternal ...

Question

A 33-year-old gravida 2 at 34 weeks in October asks about RSV protection for her newborn. She declines monoclonal antibody after birth. What maternal option is recommended?

Accepted Answer

Maternal RSV vaccine (Abrysvo) at 32-36 weeks during RSV season

Answer

Maternal RSV vaccine at any time in pregnancy

Answer

RSV live-attenuated vaccine postpartum

Answer

No maternal option; only infant monoclonal exists

Answer

Influenza vaccine substitutes for RSV protection

us-abfm MCQ (SBA): RSV Prevention (Maternal)

A 33-year-old gravida 2 at 34 weeks in October asks about RSV protection for her newborn. She declines monoclonal antibody after birth. What maternal option is recommended?